Search

everythinglearnresearchcommunity

for

Search:↓

An infant with complete hair loss was diagnosed with a genetic disorder affecting hair growth.

Post-COVID-19 patients often experience musculoskeletal issues, fitness decline, behavioral changes, chest pain, cough, hair loss, and nervous system problems.

COVID-19 can cause long-term lung, skin, and mental health problems, especially in women, people with other health issues, and those who had severe COVID-19.

Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.

Older men with diabetes were more likely to get severe COVID-19 and needed treatments like antivirals for about 2-3 weeks.

Long COVID recovery is hindered by smoking, with hair loss being a difficult symptom to treat.

There have been major advances in diagnosing and treating hair loss over the last 30 years, with new drugs and improved hair transplant techniques.

The pandemic likely caused delays in skin cancer assessments, leading to fewer early diagnoses and thicker melanomas.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

People with severe alopecia areata often have lower vitamin D levels and may have other autoimmune or allergic conditions.

Sex hormones likely did not affect COVID-19 outcomes in South Korea.

Vitiligo is often found with other autoimmune diseases, which is important to know to help patients.

Type 3 acromegaly patients have more health issues and higher death risk.

Obesity significantly affects skin health, causing conditions like acanthosis nigricans and skin tags, and should be considered during skin exams.

Early diagnosis and treatment can prevent or delay frontal fibrosing alopecia progression in postmenopausal women.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

Older patients with advanced kidney cancer can be managed with a drug called Sunitinib.

Women in Australia report different signs of facial aging compared to women in the US, UK, and Canada; men with Lichen planopilaris often have hormonal abnormalities and thyroid disease.

Most men with lichen planopilaris had it confirmed by biopsy and often had thyroid issues, sexual dysfunction, or prostate cancer, hinting at a link with hormonal problems.

The case shows skin changes can indicate deeper health issues like insulin resistance, which are challenging to manage.

Polycystic Ovary Syndrome (PCOS) affects 6%-15% of women of reproductive age, causing symptoms like acne and hair loss, and increasing the risk of type 2 diabetes and heart disease; it's managed through diet, exercise, and medications like Metformin and hormonal contraceptives.

Women with PCOS often have hirsutism and skin changes, which indicate a need for metabolic health checks.

Hirsutism and acanthosis nigricans are reliable skin signs of PCOS linked to metabolic issues, while acne is not a reliable marker of the condition.

Addressing anxiety and mood disorders is crucial to reduce medication overuse in chronic migraine patients.

Androgenetic alopecia is linked to higher cardiovascular and metabolic risks, possibly due to irisin resistance.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Women know more about androgenetic alopecia than men.

New methods can diagnose hair loss by examining the scalp and can treat it with a mix of oral and topical medications, along with cosmetic procedures like hair transplants.

Hair diseases can have psychological effects and should be treated with a combination of psychosomatic care, therapy, and medication.

People with polycystic ovary syndrome often experience anxiety and depression.